Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2018

Every FDA drug recall initiated in 2018, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

1,681 recalls, newest first.

Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-644-01 D-0358-2019
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-633-01 D-0357-2019
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-622-01 D-0356-2019
Class I · High risk

Ceftriaxone for Injection USP

Presence of Particulate Matter: Product complaints received of grey flecks, identified as shredded rubber particulate matter from the stopper observed in reconstituted vials.

Terminated Particulate / foreign matter Lupin Pharmaceuticals Inc. NDC 68180-611-01 D-0355-2019
Class II · Moderate risk

Oxygen

CGMP Deviations

Terminated cGMP deviation Roberts Home Medical LLC D-1002-2019
Class II · Moderate risk

Cidofovir Dihydrate

CGMP Deviations: Active Pharmaceutical Ingredient (API) manufacturer is on FDA Import Alert.

Terminated cGMP deviation LGM Pharma LLC D-0486-2019

Recalls by year